Dimensional Fund Advisors LP Boosts Stock Position in Synopsys, Inc. $SNPS

Dimensional Fund Advisors LP boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 28.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 470,225 shares of the semiconductor company's stock after buying an additional 103,251 shares during the period. Dimensional Fund Advisors LP owned approximately 0.25% of Synopsys worth $186,392,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in SNPS. Sankala Group LLC bought a new position in shares of Synopsys during the fourth quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Synopsys in the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new position in Synopsys in the 4th quarter worth about $28,000. Atlas Capital Advisors Inc. bought a new position in Synopsys in the 4th quarter worth about $32,000. Finally, Geneos Wealth Management Inc. grew its position in Synopsys by 151.5% during the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company's stock valued at $33,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on SNPS. Benchmark began coverage on shares of Synopsys in a research note on Wednesday, July 15th. They set a "buy" rating and a $570.00 price objective for the company. Needham & Company LLC reiterated a "buy" rating and issued a $580.00 target price on shares of Synopsys in a research note on Thursday, May 28th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a report on Thursday, May 28th. Bank of America raised their price target on shares of Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a research report on Thursday, May 28th. Finally, Wells Fargo & Company boosted their price objective on shares of Synopsys from $505.00 to $535.00 and gave the stock an "equal weight" rating in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $570.06.

Insider Activity at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of the business's stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company's stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.

Synopsys Trading Down 0.0%

Synopsys stock opened at $373.47 on Friday. Synopsys, Inc. has a one year low of $366.00 and a one year high of $651.73. The business's fifty day moving average is $456.13 and its 200 day moving average is $455.25. The stock has a market capitalization of $71.51 billion, a PE ratio of 86.45, a price-to-earnings-growth ratio of 2.19 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys's revenue was up 41.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.65 EPS for the current year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.